Nearly 2 million 23andMe users deleted their DNA data after bankruptcy. Here's why the genetic testing industry should be ...

Privacy concerns mount as 23andMe bankruptcy sale nears. Ombudsman warns of data protection risks under nonprofit bid led by ...

BioNTech has agreed to buy another specialist in mRNA-based vaccines and therapeutics, fellow German biotech CureVac, in an all-stock deal valued at around $1.25 billion.

The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.

Oregon Attorney General Dan Rayfield said the data is “too sensitive” to be sold without users’ informed consent.

Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...

During a hearing on the privacy implications of 23andMe selling its business, its interim CEO says 1.9 million people, or ...

Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

A number of US states are taking legal action against the sale of 23andMe and its DNA data. A sale is only acceptable with ...

Multiple states and the District Columbia are pushing back on bankrupt 23andMe’s plans to sell customer genetic information ...

Me was founded in 2006 and pioneered the direct-to-consumer genetic testing model. Customers responded positively, ordering ...

A hearing this week marked a critical juncture in the national conversation about the intersection of biotechnology, privacy, ...